J Appl Biomed 11:15-26, 2013 | DOI: 10.2478/v10136-012-0014-y

Antiparasitic effects of Zingiber officinale (Ginger) extract against Toxoplasma gondii

WonHyung Choi*, MeiHua Jiang, JongPhil Chu
Department of Medical Zoology, Kyung Hee University School of Medicine, Seoul, Republic of Korea

Zingiber officinale Roscoe, Ginger, has been used in folk medicine as a medicinal plant, as well as a spice and food in many countries. This research was carried out to evaluate the antiparasitic effect of ginger root extract (GE) and GE/F1 (fraction 1 obtained from GE) against Toxoplasma gondii (T. gondii) in vitro and in vivo. The effects of GE and GE/F1 against the proliferation of T. gondii-infected C6 cells and T. gondii were evaluated by several indicators such as an MTT assay, nuclear staining, immunofluorescence staining, apoptotic proteins and animal testing. GE/F1 strongly inhibited the proliferation of T. gondii-infected C6 cells and T. gondii in a dose-dependent manner compared with sulfadiazine. After T. gondii invasion, C6 cells induced the activation of caspase-3, bax, p53 and p21 related to programmed cell death, and GE/F1 effectively suppressed the expression of caspase-3, bax, p53 and p21 causing cell death of the infected host cells. In addition, INF-γ, and IL-8 levels, and the viability of T. gondii-infected mice treated with GE/F1 (500 μg/ml) were not changed or increased during the period of the experiment. These results demonstrate that GE/F1 not only induces anti-T. gondii effects causing the inactivation of apoptotic proteins in infected host cells through the direct inhibition of T. gondii but also has antiparasitic properties which inhibit inflammatory cytokine secretion in vivo.

Keywords: apoptotic protein; C6 glioma cells; cytokine; p53; programmed cell death

Received: December 8, 2011; Revised: February 28, 2012; Published: March 31, 2013  Show citation

ACS AIP APA ASA Harvard Chicago IEEE ISO690 MLA NLM Turabian Vancouver
Choi W, Jiang M, Chu J. Antiparasitic effects of Zingiber officinale (Ginger) extract against Toxoplasma gondii. J Appl Biomed. 2013;11(1):15-26. doi: 10.2478/v10136-012-0014-y.
Download citation

References

  1. Agarwal ML, Taylor WR, Chernov MV, Chernova OR, Stark, GR. The p53 network. J Biol Chem. 273: 1-4, 1998. Go to original source... Go to PubMed...
  2. Choi WH, Chu JP, Jiang MH, Baek SH, Park HD. Effects of Fraction obtained from Korean Corni Fructus extracts causing anti-proliferation and p53-dependent apoptosis in A549 lung cancer cells. Nutr Cancer. 63: 121-129, 2011. Go to original source... Go to PubMed...
  3. DeFeudis FV, Papadopouls V, Drieu K. Ginkgo biloba extracts and cancer: a research area in its infancy. Fundam Clin Pharmacol. 17: 405-417, 2003. Go to original source... Go to PubMed...
  4. Dubey JP, Lindsay DS, Speer CA. Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts. Clin Microbiol Rev. 11: 267-299, 1998. Go to original source... Go to PubMed...
  5. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell. 75: 817-825, 1993. Go to original source... Go to PubMed...
  6. Endo K, Kanno E, Oshima Y. Structures of antifungal diarylheptenones, gingerenones A, B, C and isogingerenone B, isolated from the rhizomes of Zingiber officinale. Phytochemistry. 29: 797-799, 1990. Go to original source...
  7. Ernst E, Pittler MH. Efficacy of ginger for nausea and vomiting: a systematic review of randomized clinical trials. Br J Anaesth. 84: 367-371, 2000. Go to original source... Go to PubMed...
  8. Ficker CE, Arnason JT, Vindas PS, Alvarez LP, Akpaqana K, Gbeassor M, De SC, Smith ML. Inhibition of human pathogenic fungi by ethnobotanically selected plant extracts. Mycoses. 46: 29-37, 2003. Go to original source... Go to PubMed...
  9. Fiore C, Eisenhut M, Krausse R, Raqazzi E, Pellati D, Armanini D. Antiviral effects of Glycyrrhiza species. Phytother Res. 22: 141-148, 2008. Go to original source... Go to PubMed...
  10. Gartel AL, Radhakrishnan SK. Lost in transcription: p21 repression, mechanisms, and consequences. Cancer Res. 65: 3980-3985, 2005. Go to original source... Go to PubMed...
  11. Grzanna R, Lindmark L, Frondoza CG. Ginger-an herbal medicinal product with broad anti-inflammatory actions. J Med Food. 8: 125-132, 2005. Go to original source... Go to PubMed...
  12. Gubbels MJ, White M, Szatanek T. The cell cycle and Toxoplasma gondii cell division: Tightly knit or loosely stitched. Int J Parasitol. 38: 1343-1358, 2008. Go to original source... Go to PubMed...
  13. Gupta VK, Fatima A, Faridi U, Neqi AS, Shanker K, Kumar JK. Antimicrobial potential of Glycyrrhiza glabra roots. J Ethnopharmacol. 116: 377-380, 2008. Go to original source... Go to PubMed...
  14. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 75: 805-816, 1993. Go to original source... Go to PubMed...
  15. Hasenöhrl RU, Topic B, Frisch C, Häcker R, Mattern CM, Huston JP. Dissociation between anxiolytic and hypomnestic effects for combined extracts of Zingiber officinale and Ginkgo biloba, as opposed to diazepam. Pharmacol Biochem Behav. 59: 527-535, 1998. Go to original source... Go to PubMed...
  16. Hiserodt RD, Franzblau SG, Rosen RT. Isolation of 6-, 8-, and 10-Gingerol from Ginger Rhizome by HPLC and Preliminary Evaluation of Inhibition of Mycobacterium avium and Mycobacterium tuberculosis. J Agric Food Chem. 46: 2504-2508, 1998. Go to original source...
  17. Jaqetia GC, Baliqa MS, Venkatesh P, Ulloor JN. Influence of ginger rhizome (Zingiber officinale Ros) on survival, glutathione and lipid peroxidation in mice after whole-body exposure to gamma radiation. Radiat Res. 160: 584-592, 2003. Go to original source... Go to PubMed...
  18. Joiner KA, Roos DS. Secretory traffic in the eukaryotic parasite Toxoplasma gondii: less is more. J Cell Biol. 157: 557-563, 2002. Go to original source... Go to PubMed...
  19. Kanazawa M, Satomi Y, Mizutani Y, Ukimura O, Kawauchi A, Sakai T. Isoliquiritigenin inhibits the growth of prostate cancer. Eur Urol. 43: 580-586, 2003. Go to original source... Go to PubMed...
  20. Kikuzaki H, Tsai SM, Nakatani N. Gingerdiol related compounds from the rhizomes of Zingiber officinale. Phytochemistry. 31: 1783-1786, 1992. Go to original source...
  21. Kotakadi VS, Jin Y, Hofseth AB, Ying L, Cui X, Volate S, Chumanevich A, Wood PA, Price RL, McNeal A, Singh UP, Singh NP et al. Ginkgo biloba extract EGb 761 has anti-inflammatory properties and ameliorates colitis in mice by driving effector T cell apoptosis. Carcinogenesis. 29: 1799-1806, 2008. Go to original source... Go to PubMed...
  22. Laliberte J, Carruthers VB. Host cell manipulation by human pathogen Toxoplasma gondii. Cell Mol Life Sci. 65: 1900-1915, 2008. Go to original source... Go to PubMed...
  23. Latt SA, Stetten G. Spectral studies on 33258 Hoechst and related bisbenzimidazole dyes useful for fluorescent detection of deoxyribonucleic acid synthesis. J Histochem Cytochem. 24: 24-33, 1976. Go to original source... Go to PubMed...
  24. Luft BJ, Remington JS. Toxoplasmic encephalitis in AIDS. Clin Infect Dis. 15: 211-222, 1992. Go to original source... Go to PubMed...
  25. Ma J, Jin X, Yang L, Liu ZL. Diarylheptanoids from the rhizomes of Zingiber officinale. Phytochemistry. 65: 1137-1143, 2004. Go to original source... Go to PubMed...
  26. Mazzanti G, Mascellino MT, Battinelli L, Coluccia D, Manganaro M, Saso L. Antimicrobial investigation of semipurified fractions of Ginkgo biloba leaves. J Ethnopharmacol. 71: 83-88, 2000. Go to original source... Go to PubMed...
  27. Morgan DO. Principles of CDK regulation. Nature. 374: 131-134, 1995. Go to original source... Go to PubMed...
  28. Nievergelt A, Huonker P, Schoop R, Altmann KH, Gertsch J. Identification of serotonin 5-HT1A receptor partial agonists in ginger. Bioorg Med Chem. 18: 3345-3351, 2010. Go to original source... Go to PubMed...
  29. Singh G, Kapoor IP, Singh P, de Heluani CS, de Lampasona MP, Catalan CA. Chemistry, antioxidant and antimicrobial investigations on essential oil and oleoresins of Zingiber officinale. Food Chem Toxicol. 46: 3295-3302, 2008. Go to original source... Go to PubMed...
  30. Shukla Y, Singh M. Cancer preventive properties of ginger: a brief review. Food Chem Toxicol. 45: 683-690, 2007. Go to original source... Go to PubMed...
  31. Topic B, Hasenöhrl RU, Häcker R, Huston JP. Enhanced conditioned inhibitory avoidance by a combined extract of Zingiber officinale and Ginkgo biloba. Phytother Res. 16: 312-315, 2002. Go to original source... Go to PubMed...
  32. Vishwakarma SL, Pal SC, Kasture VS, Kasture SB. Anxiolytic and antiemetic activity of Zingiber officinale. Phytother Res. 16: 621-626, 2002. Go to original source... Go to PubMed...
  33. Yamahara J, Mochizuki M, Rong HQ, Matsuda H, Fujimura H. The anti-ulcer effect in rats of ginger constituents. J Ethnopharmacol. 23: 299-304, 1988. Go to original source... Go to PubMed...
  34. Yang XM, Chen SX, Xia L, Chen J. Molluscicidal activity against Oncomelania hupensis of Ginkgo biloba. Fitoterapia. 79: 250-254, 2008. Go to original source... Go to PubMed...